Word: saharan
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...world, so stuffed that the facts run into one another and thus seem, in a weird way, to be immaterial. The argument for lowering the prices of anti-AIDS drugs does not depend on whether 40 percent of the people under the age of 20 in sub-Saharan Africa have HIV or 20 percent of the people under the age of 40 do. Either way, there are many people for whom the drugs are far too expensive because pharmaceutical companies are unwilling to lower their profit margins. The sad fact is that though Galeano is continually pointing out the obvious...
Nearly 130 members of the Harvard faculty signed a statement released yesterday calling on developed countries to give $1.1 billion a year to fight AIDS in sub-Saharan Africa...
...dismayed by the slaughterhouse that Europe has become as foot-and-mouth disease ravages livestock [NOTEBOOK, March 19]. It is especially upsetting because it comes so closel y on the heels of the BSE epidemic. What would happen if these diseases spread to sub-Saharan Africa? Here, there are few slaughterhouses, but where they do exist, blood and waste run into open waterways from which the towns and villages take their drinking water. MOSES IDA-MICHAELS Lagos, Nigeria...
...protease inhibitor Crixivan, to Africa at the reduced price of $600 per year. AIDS drugs typically cost between $10,000 and $15,000 per year. Needless to say, because of these exorbitantly high prices, these drugs are out of reach for those most in need--especially those in sub-Saharan Africa, quickly becoming the center of the global AIDS pandemic...
...cruel calculus of the AIDS epidemic, the best anti-AIDS drugs almost never reach the millions of people who need them most. In the face of the widespread epidemic in sub-Saharan Africa--where more than 25 million people are HIV positive--pharmaceutical companies have been under increasing pressure to supply the developing world with cut-rate medicines. But no matter how much they trim prices on a combination-drug regimen that can cost $15,000 a year in the U.S., it's never quite enough to make a dent in countries where per capita annual income is only...